EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Imaging Molecular Targets and Metabolic Pathways in Breast Cancer for Improved Clinical Management: Current Practice and Future Perspectives

Honest Ndlovu iD, Ismaheel O Lawal iD, Kgomotso M G Mokoala iD, Mike M Sathekge iD

International Journal of Molecular Sciences · 26.01.2024 · 25 (3) · 1575

DOI: 10.3390/ijms25031575 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.01.2024. Verfasst von Honest Ndlovu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most frequently diagnosed cancer and leading cause of cancer-related deaths worldwide. Timely decision-making that enables implementation of the most appropriate therapy or therapies is essential for achieving the best clinical outcomes in breast cancer. While clinicopathologic characteristics and immunohistochemistry have traditionally been used in decision-making, these clinical and laboratory parameters may be difficult to ascertain or be equivocal due to tumor heterogeneity. Tumor heterogeneity is described as a phenomenon characterized by spatial or temporal phenotypic variations in tumor characteristics. Spatial variations occur within tumor lesions or between lesions at a single time point while temporal variations are seen as tumor lesions evolve with time. Due to limitations associated with immunohistochemistry (which requires invasive biopsies), whole-body molecular imaging tools such as standard-of-care [18F]FDG and [18F]FES PET/CT are indispensable in addressing this conundrum. Despite their proven utility, these standard-of-care imaging methods are often unable to image a myriad of other molecular pathways associated with breast cancer. This has stimulated interest in the development of novel radiopharmaceuticals targeting other molecular pathways and processes. In this review, we discuss validated and potential roles of these standard-of-care and novel molecular approaches. These approaches’ relationships with patient clinicopathologic and immunohistochemical characteristics as well as their influence on patient management will be discussed in greater detail. This paper will also introduce and discuss the potential utility of novel PARP inhibitor-based radiopharmaceuticals as non-invasive biomarkers of PARP expression/upregulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemalePositron Emission Tomography Computed TomographyRadiopharmaceuticalsFluorodeoxyglucose F18Whole Body ImagingMetabolic Networks and PathwaysPositron-Emission Tomography

Stichwörter der Autor:innen

PARP imagingbreast cancerimmunohistochemistryreceptor expressionstandard imagingtumor heterogeneitytumor microenvironment

Substanzen

RadiopharmaceuticalsFluorodeoxyglucose F18

Autor:innen und Institutionen

  • Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.
  • Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Private Bag X169, Pretoria 0001, South Africa.
  • Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30322, USA.

ORCID-Profile: Honest Ndlovu, Ismaheel O Lawal, Kgomotso M G Mokoala, Mike M Sathekge

Zitieren

APA

Ndlovu, H., Lawal, I. O., Mokoala, K. M. G., & Sathekge, M. M. (2024). Imaging Molecular Targets and Metabolic Pathways in Breast Cancer for Improved Clinical Management: Current Practice and Future Perspectives. International Journal of Molecular Sciences, 25(3), 1575. https://doi.org/10.3390/ijms25031575

Vancouver

Ndlovu H, Lawal IO, Mokoala KMG, Sathekge MM. Imaging Molecular Targets and Metabolic Pathways in Breast Cancer for Improved Clinical Management: Current Practice and Future Perspectives. International Journal of Molecular Sciences. 2024;25(3):1575. doi:10.3390/ijms25031575

BibTeX
@article{Ndlovu2024,
  author = {Ndlovu, Honest and Lawal, Ismaheel O and Mokoala, Kgomotso M G and Sathekge, Mike M},
  title = {Imaging Molecular Targets and Metabolic Pathways in Breast Cancer for Improved Clinical Management: Current Practice and Future Perspectives},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {3},
  pages = {1575},
  doi = {10.3390/ijms25031575}
}
Kostenlos starten →